Mind your modifiers: Report and document drug waste as of Jan. 1 or lose out on revenue

Why This Topic Matters

Correct handling of discarded drug reporting affects payment accuracy, compliance, and audit exposure. The article helps readers understand the documentation and billing topics covered by CMS and related oversight resources so they can evaluate whether their current workflow supports compliant claim submission.

Article Sections

1. Modifier JW and CMS policy background

   Introduces the topic of discarded drug reporting and summarizes the Medicare Part B policy context discussed in the article. It frames the broader documentation, billing, and payment considerations that follow.

2. Document what’s discarded

   Focuses on chart documentation expectations for wasted medication and where that information should appear in the record. It also references CMS and related guidance materials discussed in the article.

3. Know when and how to use JW

   Covers general reporting circumstances for discarded drug amounts from single-use products and gives a broad example of the claim reporting workflow. The section stays centered on proper use context rather than detailed instruction.

4. Know when not to use JW

   Reviews situations discussed in the article where the modifier is not appropriate and highlights the need for continued documentation even when the modifier is not used. It also references examples tied to drug billing and label language.

5. Watch your carriers

   Notes that carrier-specific billing requirements may supplement national guidance and that local resources can change over time. This section emphasizes staying current with payer instructions and related references.